Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rapoport

Showing results (131-140 of 179) with videos related to

Pageof 18
Sort By:
European Journal of Haematology|May 12, 2026
Real-World Experience With a ZUMA-1 Cohort 4 Adopted Approach to CRS and ICANS in CAR-T RecipientsChiranjeevi Sainatham, Olga Goloubeva, Philip Margiotta, et al.
International Journal of Radiation Oncology, Biology, Physics|June 9, 2019
Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell LymphomaAustin J Sim, Michael D Jain, Nicholas B Figura, et al.
Bone Marrow Transplantation|November 2, 2004
Autologous stem cell transplantation followed by consolidation chemotherapy for relapsed or refractory Hodgkin's lymphomaA P Rapoport, C Guo, A Badros, et al.
Biomolecules|July 29, 2025
Defibrotide for Protecting Against and Managing Endothelial Injury in Hematologic Malignancies and COVID-19Edward Richardson, Clifton C Mo, Eleonora Calabretta, et al.
Blood Advances|October 3, 2019
T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myelomaAlfred L Garfall, Ehren K Dancy, Adam D Cohen, et al.
Signal Transduction and Targeted Therapy|April 22, 2026
Preventing trogocytosis by cathepsin B inhibition augments CAR T-cell functionKenneth A Dietze, Kiet Nguyen, Aashli Pathni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplantsA P Rapoport, L F Miller Watelet, T Linder, et al.
Blood Advances|October 8, 2020
Successful transfer of anti-SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19Tim Luetkens, Ryan Metcalf, Vicente Planelles, et al.
Neuro-Oncology|August 5, 2020
Immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomesNoa G Holtzman, Hao Xie, Soren Bentzen, et al.
Journal for Immunotherapy of Cancer|July 15, 2020
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myelomaNina Shah, Jack Aiello, David E Avigan, et al.
Pageof 18

Showing results (131-140 of 179) with videos related to

Sort By:
Pageof 18
European Journal of Haematology|May 12, 2026
Real-World Experience With a ZUMA-1 Cohort 4 Adopted Approach to CRS and ICANS in CAR-T RecipientsChiranjeevi Sainatham, Olga Goloubeva, Philip Margiotta, et al.
International Journal of Radiation Oncology, Biology, Physics|June 9, 2019
Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell LymphomaAustin J Sim, Michael D Jain, Nicholas B Figura, et al.
Bone Marrow Transplantation|November 2, 2004
Autologous stem cell transplantation followed by consolidation chemotherapy for relapsed or refractory Hodgkin's lymphomaA P Rapoport, C Guo, A Badros, et al.
Biomolecules|July 29, 2025
Defibrotide for Protecting Against and Managing Endothelial Injury in Hematologic Malignancies and COVID-19Edward Richardson, Clifton C Mo, Eleonora Calabretta, et al.
Blood Advances|October 3, 2019
T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myelomaAlfred L Garfall, Ehren K Dancy, Adam D Cohen, et al.
Signal Transduction and Targeted Therapy|April 22, 2026
Preventing trogocytosis by cathepsin B inhibition augments CAR T-cell functionKenneth A Dietze, Kiet Nguyen, Aashli Pathni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplantsA P Rapoport, L F Miller Watelet, T Linder, et al.
Blood Advances|October 8, 2020
Successful transfer of anti-SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19Tim Luetkens, Ryan Metcalf, Vicente Planelles, et al.
Neuro-Oncology|August 5, 2020
Immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomesNoa G Holtzman, Hao Xie, Soren Bentzen, et al.
Journal for Immunotherapy of Cancer|July 15, 2020
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myelomaNina Shah, Jack Aiello, David E Avigan, et al.
Pageof 18